![Byoung-Chul Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 12 M $ as of 2026-07-30
Byoung-Chul Lee is Chief Executive Officer & Director at Kanaph Therapeutics, Inc. since 2019.
Dr. Lee is the founder of Kanaph Therapeutics, Inc., founded in 2019.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KANAPH THERAPEUTICS INC. 11.84% | 2026-03-30 | 1,570,482 ( 11.84% ) | 12 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| KANAPH THERAPEUTICS INC. | Founder | 2019-02-13 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 1 |
|---|---|
KANAPH Therapeutics, Inc.
 KANAPH Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug, antibodies, medical and pharmaceutical research and development business services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
